Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 7/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5596483 | 0.82 | C5AR1 (0.35) | C5AR1 | |
| SCHEMBL5596310 | 0.81 | HTR2C (0.41) | — | |
| SCHEMBL5596687 | 0.81 | — | — | |
| SCHEMBL5596986 | 0.81 | C5AR1 (0.39) | C5AR1PARP1GRIN1GRIN2B | |
| SCHEMBL5597041 | 0.79 | PARP1 (0.36) | C5AR1PARP1GRIN1GRIN2B | |
| SCHEMBL5597226 | 0.78 | PTPN11 (0.36) | — | |
| SCHEMBL5597033 | 0.77 | HTR2C (0.44) | — | |
| SCHEMBL5596688 | 0.75 | PARP1 (0.37) | C5AR1PARP1GRIN1GRIN2B | |
| SCHEMBL5596427 | 0.75 | HTR2C (0.46) | — | |
| SCHEMBL31134547 | 0.74 | PARP1 (0.38) | C5AR1PARP1GRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1829876-A1 | NITROGENEOUS TRICYCLIC COMPOUND | Asahi Kasei Pharma Corporation (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20060247266-A1 | Nitrogen-containing tricyclic compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2006-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247266-A1 | Nitrogen-containing tricyclic compounds | MYO1B, CHRM1, MYL12A | C5AR1 340/4885PARP1 2408/4885GRIN1 798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.